Bryan J. McMichael - Jan 7, 2025 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ Bryan J. McMichael
Stock symbol
CHRS
Transactions as of
Jan 7, 2025
Transactions value $
-$2,686
Form type
4
Date filed
1/10/2025, 04:03 PM
Previous filing
Jan 7, 2025
Next filing
Jan 22, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$2.69K -1.71K -6.49% $1.57 24.7K Jan 7, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
F2 Includes 3,401 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.